Designing a Cell Therapy Clinical Trial for Acute Care Indications: Resolving the Paradox
Friday, May 31, 2024 03:45 PM - 04:45 PM
Room 205-207
Roundtable
Moderators
Overcome challenges to designing a large-scale clinical trial for patients requiring immediate care, including patient selection, harmonization of outcome measures, patient monitoring and de-risking.
Key Learning Objectives
1. Clinical trial design for cell and cell-product clinical trial design
2. Efficacy – harmonization of outcome measures, monitoring and de-risking
3. Obstacles to deployment of the therapy in larger scales clinical trials
- Claudia Dos Santos, MD, MSc, FRCPC, Institution The Keenan Research Centre for Biomedical Science of St. Michael’s Hospital, University of Toronto, Canada
- Patricia R.M. Rocco, MD, PhD, Institution Federal University of Rio de Janeiro, Brazil
- Daniel Weiss, MD, PhD, University of Vermont, United States
- Maroun Khoury, PhD, IMPACT - Center of Interventional Medicine for Precision and Advanced Cellular Therapy, Chile
- Duncan J. Stewart, MD, Ottawa Hospital Research Institute, Canada
Overcome challenges to designing a large-scale clinical trial for patients requiring immediate care, including patient selection, harmonization of outcome measures, patient monitoring and de-risking.
Key Learning Objectives
1. Clinical trial design for cell and cell-product clinical trial design
2. Efficacy – harmonization of outcome measures, monitoring and de-risking
3. Obstacles to deployment of the therapy in larger scales clinical trials
Maroun Khoury
Executive Director
IMPACT-Center of interventional medicine for precision and advanced cellular therapy
Panelist
Executive Director
IMPACT-Center of interventional medicine for precision and advanced cellular therapy
Panelist
